Showing results (111-120 of 226) with videos related to
Sort By:
Pageof 23
The American Journal of Gastroenterology|March 26, 2019
Efficacy of Fecal Microbiota Transplantation in Irritable Bowel Syndrome: A Systematic Review and Meta-AnalysisDabo Xu, Vincent L Chen, Calen A Steiner, et al.The American Journal of Managed Care|July 19, 2018
5-ASA to sulfasalazine drug switch program in patients with ulcerative colitisJason R Goldsmith, Akbar K Waljee, Tom George, et al.Journal of Ultrasound in Medicine : Official Journal of the American Institute of Ultrasound in Medicine|November 27, 2014
Ultrasound shear wave elastography helps discriminate low-grade from high-grade bowel wall fibrosis in ex vivo human intestinal specimensJonathan R Dillman, Ryan W Stidham, Peter D R Higgins, et al.Gut|February 15, 2011
A randomised trial of sheathed versus standard forceps for obtaining uncontaminated biopsy specimens of microbiota from the terminal ileumManeesh Dave, Laura A Johnson, Seth T Walk, et al.Crohn'S & Colitis 360|February 13, 2023
Safety, Pharmacokinetics, and Efficacy of Olorinab, a Peripherally Acting, Highly Selective, Full Agonist of the Cannabinoid Receptor 2, in a Phase 2a Study of Patients With Chronic Abdominal Pain Associated With Crohn's DiseaseBruce R Yacyshyn, Stephen Hanauer, Preston Klassen, et al.Alimentary Pharmacology & Therapeutics|January 22, 2019
Long-term safety and tolerability of oral tofacitinib in patients with Crohn's disease: results from a phase 2, open-label, 48-week extension studyJulián Panés, Geert R D'Haens, Peter D R Higgins, et al.Gastroenterology|July 26, 2011
Ultrasound elasticity imaging for detecting intestinal fibrosis and inflammation in rats and humans with Crohn's diseaseRyan W Stidham, Jingping Xu, Laura A Johnson, et al.The American Journal of Gastroenterology|October 31, 2013
Machine learning algorithms outperform conventional regression models in predicting development of hepatocellular carcinomaAmit G Singal, Ashin Mukherjee, B Joseph Elmunzer, et al.Digestive Diseases and Sciences|October 26, 2024
Self-Efficacy, Patient Activation, and the Burden of Inflammatory Bowel Disease on Patients' Daily LivesJessica L Sheehan, LaVana Greene-Higgs, Kenneth Resnicow, et al.Mucosal Immunology|February 12, 2019
Flagellin-mediated activation of IL-33-ST2 signaling by a pathobiont promotes intestinal fibrosisJin Imai, Sho Kitamoto, Kohei Sugihara, et al.Pageof 23